HISTOPATHOLOGIC STUDIES OF ASTHMA
哮喘的组织病理学研究
基本信息
- 批准号:6121416
- 负责人:
- 金额:$ 6.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-12-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It is now widely recognized that asthma represents the clinical
manifestations of airways disease characterized by a unique form of chronic
inflammation. Prominent in the inflammatory process are cells within the
airways such as mast cells, eosinophils, and T lymphocytes. Asthma is most
often associated with underlying atrophy, sensitization to inhaled allergens,
and elevations in production of immunoglobulin E (IgE. Such allergic and
asthmatic responses are associated with the presence of helper T
lymphocytes characterized by the production of certain cytokines
characterizing the Th2-subset of helper T lymphocytes. Th2 cytokines
include interleukin (IL-4), involved in IgE production and the differentiation
of Th2 type lymphocytes; IL-5, involved in the recruitment, activation, and
survival of circulating eosinophils accumulating in an inflammatory site;
and IL-13, sharing many of the properties of IL-4 including stimulating the
expression of adhesion molecules on endothelial cells lining the blood
vessels. Our work using the model of segmental allergen challenge of the
airways in human subjects has demonstrated specific recruitment of
eosinophils, basophils, and helper/memory T lymphocytes into the airways
in response to allergen challenge of sensitized induviduals. These findings
indicate highly selective mechanisms involved in the inflammatory response
to allergen as well as the subsequent immunologic sensitization of the
airway to exposure of a specific antigen. Underlying the inflammatory
response involving recruitment of eosinophils and basophils is the
expression and production of Th2 type cytokines including IL-4, IL-5 and
IL-13. The mechanisms by which specific cellular recruitment occurs has
been further examined by studying the effect of systemic corticosteroids on
the inflammatory response. Results clearly demonstrate multiple effects of
systemic corticosteroids including significant decreases in the number of
eosinophils, basophils and T lymphocytes recruited to the site of allergen
challenge. These effects on cellular influx were associated with inhibition of
kinin generation and plasma exudation as markers of blood vessel and
airway permeability. Increased levels of gene expression for IL-4 and IL-5,
as well as cytokine-specific protein production, was also inhibited by the
administration of corticosteroids. Production of E-selectin, one of the
adhesion molecules involved in cellular recruitment was also inhibited by
corticosteroids. Production of the cytokine IL-2 was also inhibited by steroid
administration, while expression of mRNA and production of IFNgamma
was not affected. Administration of systemic corticosteroids did not affect
the immediate release of histamine and prostaglandin D2 consistent with a
lack of effect of mast cell mediator release. These results indicate that many
of the mechanisms of recruitment of inflammatory cells involved in allergic
inflammation and asthma are inhibited by systemic corticosteroids and are
likely to involve mechanisms inhibiting the expression of cytokine genes,
cytokine production, and induction of adhesion molecules.
Our most recent studies on the mechanisms of cellular recruitment in
allergic inflammation in asthma have focused on the recruitment of allergen-
specific T cells to the site of allergen challenge. Using subjects sensitized to
multiple allergens and challenged at different times with different allergens,
i.e., dust mite or ragweed allergens, we have demonstrated that within the
purified helper T cell population is an allergen-specific T cell population
detected by allergen-specific responses to allergen stimulation in vitro. By
stimulating helper T cell populations with both allergens following different
allergen challenges in vivo, we have demonstrated that even within 20
hours, there appears to be an allergen-drivem recruitment of previously
sensitized T lymphocytes accumulating at the site of inflammation. The
results suggest that in addition to mechanisms involving recruitment of
inflammatory cells to the site of allergen challenge, there is an allergen-
specific component to the cellular response. Such findings suggest that
antigen-presenting cells such as macrophages or dendritic cells may be
involved in allergen-specific lymphocyts accumulation and immunologic
priming of the airway for response to further exposure to allergens. Such
mechanisms may be important in the perpetuation and localization of
inflammation in the asthmatic airway stimulated by exposure to allergen.
Future studies will determine whether it is the allergen-specific T cell
population recruited to the site of allergen challenge which is the source of
the Th2 cytokine profile demonstrated in the mixed cell population
accumulating following allergen challenge.
现在人们普遍认为哮喘代表着临床上的
以一种独特的慢性呼吸道疾病为特征的呼吸道疾病的表现
发炎。炎症过程中突出的是内皮细胞
如肥大细胞、嗜酸性粒细胞和T淋巴细胞等。哮喘是最常见的
通常与潜在的萎缩有关,对吸入的过敏原敏感,
以及提高免疫球蛋白E(IgE)的产量。如此过敏和
哮喘反应与辅助性T细胞的存在有关
以产生某些细胞因子为特征的淋巴细胞
辅助性T淋巴细胞的Th2亚群的特征。Th2细胞因子
包括白介素4(IL-4),参与IgE的产生和分化
Th2型淋巴细胞;IL-5,参与募集、激活和
炎症部位聚集的循环嗜酸性粒细胞存活;
和IL-13,分享了IL-4的许多特性,包括刺激
血管内皮细胞表面黏附分子的表达
船只。我们的工作使用节段性变应原挑战的模型
在人类受试者中的航空公司已经展示了具体的招募
嗜酸性粒细胞、嗜碱性粒细胞和辅助/记忆T淋巴细胞进入呼吸道
以应对致敏行业的过敏原挑战。这些发现
提示参与炎症反应的高度选择性机制
变应原以及随后的免疫致敏作用
暴露于特定抗原的呼吸道。在炎症性疾病背后
涉及嗜酸性粒细胞和嗜碱性粒细胞招募的反应是
Th2型细胞因子IL-4、IL-5和IL-2的表达和产生
IL-13。发生特定细胞募集的机制有
通过研究全身性皮质类固醇对
炎症反应。结果清楚地表明,
全身性皮质类固醇激素,包括
嗜酸性粒细胞、嗜碱性粒细胞和T淋巴细胞被招募到变应原部位
挑战。这些对细胞内流的影响与抑制
激肽生成和血浆渗出作为血管和免疫功能的标志物
呼吸道通透性。IL-4和IL-5基因表达水平升高,
以及细胞因子特异性蛋白的产生,也被抑制
皮质类固醇的使用。E-选择素的生产
参与细胞募集的黏附分子也受到抑制
皮质类固醇。类固醇也抑制了细胞因子IL-2的产生
给药,同时mRNA表达和干扰素-γ的产生
没有受到影响。全身性皮质类固醇的使用不影响
组胺和前列腺素D2的即刻释放符合
缺乏肥大细胞介质释放的作用。这些结果表明,许多
过敏性炎症细胞募集机制的研究进展
全身皮质类固醇激素可抑制炎症和哮喘
可能涉及到抑制细胞因子基因表达的机制,
细胞因子的产生和黏附分子的诱导。
我们对细胞募集机制的最新研究
哮喘的过敏性炎症主要集中在过敏原的募集上-
特异性T细胞对变应原部位的攻击。使用敏感的对象
多种过敏原,并在不同的时间用不同的过敏原挑战,
即尘螨或豚草变应原,我们已经证明在
纯化的辅助性T细胞群是过敏原特异性的T细胞群
通过体外对过敏原刺激的过敏原特异性反应来检测。通过
用两种过敏原刺激辅助性T细胞群
体内的过敏原挑战,我们已经证明,即使在20
几个小时后,似乎有一个过敏原驱动的招募之前
致敏T淋巴细胞聚集在炎症部位。这个
结果表明,除了涉及招聘的机制外,
炎症细胞对部位的过敏原发起挑战,有一种过敏原-
细胞反应的特定成分。这些发现表明,
巨噬细胞或树突状细胞等抗原提呈细胞可能是
参与过敏原特异性淋巴细胞聚集和免疫学
为进一步暴露在过敏原中作出反应而对呼吸道进行预置。是这样的
机制可能在永久化和本地化方面很重要
因接触变应原而引起的哮喘呼吸道炎症。
未来的研究将确定它是否是过敏原特异性T细胞
人口招募到过敏原挑战的地点,这是来源
混合细胞群体中Th2细胞因子的表达
在过敏原挑战后积累。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark C Liu其他文献
Mark C Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark C Liu', 18)}}的其他基金
HISTOPATHOLOGIC STUDIES OF ALLERGIC INFLAMMATION OF AIRWAYS
气道过敏性炎症的组织病理学研究
- 批准号:
6121415 - 财政年份:1998
- 资助金额:
$ 6.52万 - 项目类别:
HISTOPATHOLOGIC STUDIES OF ALLERGIC INFLAMMATION OF AIRWAYS
气道过敏性炎症的组织病理学研究
- 批准号:
6281955 - 财政年份:1998
- 资助金额:
$ 6.52万 - 项目类别:
相似海外基金
卵巣癌/子宮体癌における薬剤感受性メチル化診断キットの開発とLiquid Biopsyへの応用
卵巢癌/子宫内膜癌药物敏感甲基化诊断试剂盒的研制及其在液体活检中的应用
- 批准号:
24K02584 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
グリオーマのliquid biopsyによるメチル化網羅的解析とprecision medicineへの応用
胶质瘤液体活检甲基化综合分析及其在精准医疗中的应用
- 批准号:
24K12271 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Liquid biopsyを用いた炎症性腸疾患の早期診断法開発
液体活检炎症性肠病早期诊断方法的开发
- 批准号:
24K10595 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
精神的長期ストレス児童の口腔細菌叢と唾液成分の解析:唾液 liquid biopsyを目指して
长期精神应激儿童口腔菌群和唾液成分分析:唾液液体活检
- 批准号:
24K13206 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
- 批准号:
10103126 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
EU-Funded
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
- 批准号:
10110442 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
EU-Funded
Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
- 批准号:
10090714 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
Collaborative R&D
肝細胞癌における術中門脈血を用いたliquid biopsyの検討
肝细胞癌术中门静脉血液体活检检查
- 批准号:
24K19404 - 财政年份:2024
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Genetic diagnosis of vascular malformations by liquid biopsy and its application to precision medicine
液体活检对血管畸形的基因诊断及其在精准医疗中的应用
- 批准号:
23K09072 - 财政年份:2023
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Breath biopsy technology targeting for volatile oxidized lipids
针对挥发性氧化脂质的呼吸活检技术
- 批准号:
23K06080 - 财政年份:2023
- 资助金额:
$ 6.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)